Form4insider filings, from the source

SEC Form 5 · accession 0001209191-16-094103

SPECTRUM PHARMACEUTICALS INC · SPPI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Rajesh C Shrotriya M.D.
Officer — Chairman & CEO · Director · 10% Owner
Period of report
Dec 31, 2015
Accepted (ET)
Jan 29, 2016 · 3:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000831547

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, $.001 Par ValueJan 7, 2015G5,943$0.00D1,708,249D
Common Stock, $.001 Par ValueDec 17, 2015G7,167$0.00D1,708,249D
Common Stock, $.001 Par ValueDec 18, 2015G52,901$0.00D1,708,249D
Common Stock, $.001 Par ValueF2Dec 18, 2015G52,901$0.00A498,894IBy CS Family Trust
Common Stock, $.001 Par ValueDec 24, 2015G51,324$0.00D1,708,249D
Common Stock, $.001 Par ValueF3Dec 24, 2015G51,324$0.00A87,018IBy Shrotriya Gift Trust
Common Stock, $.001 Par ValueF4Dec 29, 2015G4,420$0.00D73,669IBy Shrotriya Family Foundation
Common Stock, $.001 Par Valueholding———9,523IBy Spouse
Common Stock, $.001 Par Valueholding———10,613IBy Shrotriya Annuity Trust
Common Stock, $.001 Par Valueholding———26,128IBy 401(k) plan

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses